ANDA 74084, held by Teva. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74084 (Diltiazem Hydrochloride), held by Teva, was not approved, with 0 approved supplements and 0 published complete response letters.
| Diltiazem Hydrochloride30MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride60MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters